{
    "organizations": [],
    "uuid": "c778c6fc7d9cf89cda6157976953e950c9e40898",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-minerva-neurosciences-reports-q1-l/brief-minerva-neurosciences-reports-q1-loss-per-share-0-32-idUSASC09ZI5",
    "ord_in_thread": 0,
    "title": "Minerva Neurosciences Reports Q1 Loss Per Share $0.32",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Minerva Neurosciences Inc:\n* MINERVA NEUROSCIENCES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND BUSINESS UPDATES\n* Q1 LOSS PER SHARE $0.32 * CASH, CASH EQUIVALENTS, RESTRICTED CASH AND MARKETABLE SECURITIES AS OF MARCH 31, 2018 WERE ABOUT $121.1 MILLION\n* CASH, CASH EQUIVALENTS, RESTRICTED CASH AND MARKETABLE SECURITIES AS OF MARCH 31, 2018 WERE APPROXIMATELY $121.1 MILLION Source text for Eikon:\nOur ",
    "published": "2018-05-03T19:42:00.000+03:00",
    "crawled": "2018-05-04T16:40:06.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "minerva",
        "neuroscience",
        "inc",
        "minerva",
        "neuroscience",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "business",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "cash",
        "cash",
        "equivalent",
        "restricted",
        "cash",
        "marketable",
        "security",
        "march",
        "million",
        "cash",
        "cash",
        "equivalent",
        "restricted",
        "cash",
        "marketable",
        "security",
        "march",
        "approximately",
        "million",
        "source",
        "text",
        "eikon"
    ]
}